ERK1/2 in immune signalling

Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biochemical Society transactions Ročník 50; číslo 5; s. 1341
Hlavní autoři: Lucas, Richard M, Luo, Lin, Stow, Jennifer L
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 31.10.2022
Témata:
Extracellular Signal-Regulated MAP Kinases - metabolism
Humans
Inflammation
MAP Kinase Signaling System
Phosphorylation
Signal Transduction
Toll-like receptors
receptor signalling
extracellular signal-regulated kinases
cytokines
innate immunity
inflammation
ISSN:1470-8752, 1470-8752
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays an essential role downstream of immune receptors to elicit inflammatory gene expression in response to infection and cell or tissue damage. Much of this work has studied ERK1/2 activation in Toll-like receptor (TLR) pathways, providing mechanistic insights into its recruitment, compartmentalisation and activation in cells of the innate immune system. In this review, we summarise the typical activation of ERK1/2 in growth factor receptor pathways before discussing its known roles in immune cell signalling with a focus downstream of TLRs. We examine emerging research uncovering evidence of dysfunctional ERK1/2 signalling in inflammatory diseases and discuss the potential therapeutic benefit of targeting ERK1/2 pathways in inflammation.
Bibliografie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1470-8752
1470-8752
DOI:10.1042/BST20220271